Recent Updates

Share
Twitter Facebook LinkedIn Forward
Published: 
Jan 15, 2021

Blood Components

Chapter 2

Whole blood donations are separated into specific cellular (red blood cells and platelets) and plasma components. Transfusing the appropriate blood component to effectively provide for the clinical needs of patients optimizes use of donated blood.

This chapter describes the manufacturing process for the most commonly prepared blood components:

  • Red blood cells (RBC)
  • Platelets: pooled and apheresis
  • Frozen plasma (FP)
  • Apheresis fresh frozen plasma (AFFP)
  • Cryosupernatant plasma (CSP)
  • Cryoprecipitate
Transfusion
Share
Twitter Facebook LinkedIn Forward
Published: 
Oct 6, 2020

Blood Administration

Chapter 9

This chapter focuses on the principles of safe blood transfusion practices. The aim of this chapter is to develop and support the knowledge of health-care professionals involved in prescribing and administering blood components and products.

Transfusion
Modified on: 
Jan 4, 2021
Share
Twitter Facebook LinkedIn Forward

COVID-19 and transfusion medicine

http://cancovid19plasma.ca/This repository aims to support Canadian transfusion medicine health care professionals during the COVID-19 pandemic. It will be updated regularly as new information is available. In addition, the public and donors can learn more about how Canadian Blood Services is responding to COVID-19 by visiting blood.ca/covid-19.

Transfusion
more

Upcoming Events

U of T Rounds: SCD: alloimmunization prevention and management with genetic tools

Share
Twitter Facebook LinkedIn Forward
When
January 28, 2021 | 12:00PM to 1:00PM
Where

Toronto/Webinar

Presented by:

Dr. Stella Chou
Associate Professor of Pediatrics
The Children's Hospital of Philadelphia
University of Pennsylvania School of Medicine

Learning Objectives:

1.    Discuss the contribution of RH genetic variation to alloimmunization in patients with SCD.
2.    Discuss strategies to reduce alloimmunization using genetic tools.
3.    Discuss renewable sources of rare cells for antibody identification.

 

Transfusion

Topic Teaching: Consumptive Thrombohaemorrhagic Disorders

Share
Twitter Facebook LinkedIn Forward
When
February 2, 2021 | 12:00PM to 1:00PM
Where

Toronto/Webinar

Presented by:

Theodore (Ted) Earl Warkentin
MD, BSc(Med), FRCPC, FACP, FRCP (Edin)
Professor, Pathology and Molecular Medicine
Division: Hematology (Transfusion Medicine)
McMaster University

Objectives:

1.   What are useful screening blood tests for evaluation of thrombocytopenia and/or coagulopathy?
2.   What is “PTT confounding”?
3.   What is the pathogenesis of GI bleeding in aortic stenosis (Heyde’s syndrome)?

Transfusion

Topic Teaching: Immunohaematology Cases

Share
Twitter Facebook LinkedIn Forward
When
February 9, 2021 | 12:00PM to 1:00PM
Where

Toronto/Webinar

More details to follow.

 

Note: The session is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Transfusion
more

Blog

Modified on: 
Jan 18, 2021
Share
Twitter Facebook LinkedIn Forward

Chief scientist Dr. Dana Devine takes on directorship at Centre for Blood Research

Dr. Devine will bring roles together to bridge discoveries into better care

Stem Cells
Transfusion

Modified on: 
Jan 13, 2021
Share
Twitter Facebook LinkedIn Forward

Dr. Celina Montemayor-Garcia on the potential of genomics to shape the future of transfusion medicine

Dr. Celina Montemayor-Garcia is a researcher and transfusion medicine specialist whose main interest is understanding how genomics and bioinformatics can be used to improve care for transfusion patients. She spoke to us about advances in precision medicine and genomics, and what they could mean for the future of blood systems.

Transfusion

Modified on: 
Jan 11, 2021
Share
Twitter Facebook LinkedIn Forward

Breaking barriers to effective treatment for Alzheimer’s disease

Blood plasma-derived IVIg holds promise as a treatment for Alzheimer’s disease. A new study suggests that combining IVIg with a new drug delivery technique that helps get IVIg into the brain could increase its effectiveness and help make the best use of this precious treatment.

Transfusion

more